tiprankstipranks
Lucid announces publication on EsoGuard in peer-reviewed journal Medicina
PremiumThe FlyLucid announces publication on EsoGuard in peer-reviewed journal Medicina
2M ago
Lucid Diagnostics completes convertible debt refinancing
Premium
The Fly
Lucid Diagnostics completes convertible debt refinancing
3M ago
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
Premium
The Fly
Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test
3M ago
PAVmed subsidiary Veris Health awarded $1.8M NIH grant for cancer care
PremiumThe FlyPAVmed subsidiary Veris Health awarded $1.8M NIH grant for cancer care
4M ago
PAVmed announces efforts to regain Nasdaq compliance
Premium
The Fly
PAVmed announces efforts to regain Nasdaq compliance
5M ago
PAVmed’s Strategic Overhaul to Secure Nasdaq Compliance
Premium
Company Announcements
PAVmed’s Strategic Overhaul to Secure Nasdaq Compliance
5M ago
PAVmed reports Q2 adjusted EPS (84c), consensus ($1.45)
PremiumThe FlyPAVmed reports Q2 adjusted EPS (84c), consensus ($1.45)
6M ago
Pavmed (PAVM) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Pavmed (PAVM) Q2 Earnings Cheat Sheet
7M ago
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
Premium
The Fly
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100